{"entity":{"id":"sant-orsola-bologna","kind":"institution","name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola","aka":["Sant'Orsola-Malpighi","Policlinico Sant'Orsola","Istituto di Ematologia Seràgnoli"],"tldr":"Bologna's university hospital, home of the Seràgnoli haematology institute and a leading Italian centre for myeloma, lymphoma and CAR-T.","summary":"The Policlinico Sant'Orsola is the university hospital of the world's oldest university and an IRCCS for transplant and oncology. Its Seràgnoli Institute of Haematology, associated with Michele Cavo (myeloma), Pier Luigi Zinzani (lymphoma) and the GIMEMA cooperative group, has run pivotal Italian trials in myeloma transplantation and lymphoma and is one of Italy's principal CAR-T and allogeneic transplant centres. Medical oncology under Andrea Ardizzoni is active in thoracic and gastrointestinal trials, and the hospital has large paediatric oncology, surgical oncology and nuclear medicine departments. The Emilia-Romagna regional network links it with IRST Meldola.","asOf":"2026-09-09","links":[{"label":"Homepage","url":"https://www.aosp.bo.it"},{"label":"Haematology","url":"https://www.aosp.bo.it/content/ematologia"}],"tags":[],"related":[],"cancers":["multiple-myeloma","dlbcl","hodgkin-lymphoma","aml","nsclc"],"sections":["cell-therapy"],"technologies":["car-t","bispecific-antibody","allogeneic-cell-therapy"],"targets":["bcma","cd20"],"drugs":["glofitamab","teclistamab"],"companies":[],"institutions":["irst-meldola"],"pathways":[],"terms":[],"trials":[],"people":["chiara-gibertoni"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Bologna","country":"IT","lat":44.496,"lng":11.36,"institutionType":"hospital","website":"https://www.aosp.bo.it","university":"Università di Bologna","programs":["Seràgnoli haematology institute","Myeloma and lymphoma trials (GIMEMA)","CAR-T and transplantation","Thoracic oncology","Paediatric oncology"]},"route":"/institutions/sant-orsola-bologna/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"hodgkin-lymphoma","kind":"cancer","name":"Hodgkin lymphoma","route":"/cancers/hodgkin-lymphoma/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"section":[{"id":"cell-therapy","kind":"section","name":"Cell Therapy","route":"/fronts/cell-therapy/"}],"technology":[{"id":"allogeneic-cell-therapy","kind":"technology","name":"Allogeneic (off-the-shelf) cell therapy","route":"/technologies/allogeneic-cell-therapy/"},{"id":"bispecific-antibody","kind":"technology","name":"Bispecific antibodies","route":"/technologies/bispecific-antibody/"},{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"}],"target":[{"id":"bcma","kind":"target","name":"BCMA","route":"/targets/bcma/"},{"id":"cd20","kind":"target","name":"CD20","route":"/targets/cd20/"}],"drug":[{"id":"glofitamab","kind":"drug","name":"Glofitamab","route":"/drugs/glofitamab/"},{"id":"teclistamab","kind":"drug","name":"Teclistamab","route":"/drugs/teclistamab/"}],"institution":[{"id":"irst-meldola","kind":"institution","name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)","route":"/institutions/irst-meldola/"}],"person":[{"id":"chiara-gibertoni","kind":"person","name":"Chiara Gibertoni","route":"/people/chiara-gibertoni/"}]}}